Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

OXYBUTYNIN CHLORIDE

OXYBUTYNIN CHLORIDE

Standard Dose
5MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview OXYBUTYNIN CHLORIDE is listed in Drugs@FDA under application 076682 (ANDA).

Marketing status: Discontinued Active ingredient OXYBUTYNIN CHLORIDE Form and strength SYRUP;ORAL - 5MG/5ML Sponsor LANNETT CO INC Submission history Latest submission status date: 2008-10-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview OXYBUTYNIN CHLORIDE is listed in Drugs@FDA under application 076682 (ANDA). Marketing status: Discontinued Active ingredient OXYBUTYNIN CHLORIDE Form and strength SYRUP;ORAL - 5MG/5ML Sponsor LANNETT CO INC Submission history Latest submission status date: 2008-10-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.